Drug Therapy for Non-Alcoholic Steatohepatitis-Induced Liver Fibrosis
Aim. An overview of current pharmacotherapy for non-alcoholic steatohepatitis (NASH)-associated liver fibrosis.Key points. In current clinical recommendations, therapeutic measures in non-alcoholic fatty liver disease should include lifestyle change, body weight normalisation, NASH-associated liver...
में बचाया:
| मुख्य लेखक: | |
|---|---|
| स्वरूप: | Artigo |
| भाषा: | Russo |
| प्रकाशित: |
Gastro LLC
2022-01-01
|
| श्रृंखला: | Российский журнал гастроэнтерологии, гепатологии, колопроктологии |
| विषय: | |
| ऑनलाइन पहुंच: | https://www.gastro-j.ru/jour/article/view/646 |
| टैग: |
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|